Pemetrexed for Injection 25 mg (Pemetrexed (Pemetrexed Disodium Hemipentahydrate) SOLUTION) 25 MG

Pemetrexed for Injection 25 mg is a solution used in cancer treatment. This intravenous medication is designed to target specific cells in the body.

Strength

25 MG

Manufacturer / TM Owner

ACCORD HEALTHCARE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pemetrexed for Injection 25 mg is primarily used in the treatment of certain types of cancer. It works by interfering with the growth and spread of cancer cells. This medication is often used in combination with other treatments to manage various forms of cancer.

Side Effects

Common effects of Pemetrexed for Injection 25 mg may include fatigue, nausea, and vomiting. Some patients may also experience a decrease in blood cell counts, which can lead to increased susceptibility to infections. It is important to discuss any side effects with a healthcare provider.

Precautions & Warnings

Pemetrexed for Injection 25 mg should be handled with care. It is important to follow the instructions provided by a healthcare professional when administering this medication. Patients should be monitored regularly for any adverse reactions. Pregnant women and individuals with certain medical conditions should consult a healthcare provider before use.

Avoid Interactions

Pemetrexed for Injection 25 mg may interact with other medications, including certain antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs). It is important to inform a healthcare provider about all medications being taken to avoid potential interactions. Alcohol consumption should be avoided while using this medication.

Frequently Asked Questions

Pemetrexed for Injection 25 mg is used in the treatment of certain types of cancer, often in combination with other treatments.

Pemetrexed for Injection 25 mg is administered intravenously by a healthcare professional.

Common side effects may include fatigue, nausea, vomiting, and a decrease in blood cell counts.

Pregnant women should consult a healthcare provider before using Pemetrexed for Injection 25 mg.

If severe side effects occur, contact a healthcare provider immediately for guidance.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.